Hepatitis B surface antigen (HBsAg) prevalence (%) in Nigeria
Nigeria: Hepatitis B surface antigen (HBsAg) prevalence was 2.7% in 2024. ▼ Falling
Latest (2024)
2.7%
Change on year
down 3.6%
World rank
8th
of 194 countries
All-time high
3.8%
in 2017
All-time low
2.7%
in 2024
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Nigeria, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Nigeria recorded 2.7% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
The figure is down 3.6% on the previous year and down 27.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Nigeria peaked at 3.8% in 2017 and was at its lowest, 2.7%, in 2024.
Nigeria ranks 8th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Nigeria, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 3.7% | — |
| 2016 | 3.7% | +0.0% |
| 2017 | 3.8% | +2.7% |
| 2018 | 3.8% | +0.0% |
| 2019 | 3.7% | -2.6% |
| 2020 | 3.6% | -2.7% |
| 2021 | 3.4% | -5.6% |
| 2022 | 3.1% | -8.8% |
| 2023 | 2.8% | -9.7% |
| 2024 | 2.7% | -3.6% |
Nigeria compared with similar countries
- Nigeria's 2.7% is above the median for lower middle income countries, which is 0.6%, 4.5× the median. (47 countries reporting)
- Nigeria's 2.7% is above the median for Sub-Saharan Africa, which is 1.1%, 2.6× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3.7% | 3.7% | 3.8% | 5 |
| 2020s | 3.1% | 2.7% | 3.6% | 5 |
Countries ranked near Nigeria
More health data for Nigeria
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8137 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,301 deaths per 1,000 people (2090)
- Number of infants who die before age 1 257,921 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 1.14 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.17 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Nigeria?
- Hepatitis b surface antigen (hbsag) prevalence in Nigeria was 2.7% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Nigeria?
- The highest recorded value was 3.8% in 2017.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Nigeria?
- The lowest recorded value was 2.7% in 2024.
- How does Nigeria rank for hepatitis b surface antigen (hbsag) prevalence?
- Nigeria ranks 8th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Nigeria?
- Over the last ten years it is down 27.0%. The long-run trend across the full record is falling.
- Where does this Nigeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).